
Pharma Pulse 8/28/24: Further Developing Patient Services, Building Effective Diabetes Quality Improvement Initiatives & more
The latest news for pharma industry insiders.
Meghan Mullooly, Archbow Consulting’s Vice President, outlines the various types of available digital solutions when delivering patient services, while also sharing ways to drive efficiencies.
A renowned expert examines the essential elements for developing successful diabetes quality improvement programs.
Some 27% of Fortune 500 companies cite AI regulation as a risk in their annual reports.
Following FDA authorization and CDC recommendation, Rite Aid announced that scheduling is now available for eligible customers seeking the updated COVID-19 (2024-2025) vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest. Appointments are available immediately.
Another piece discussing how #AI will help not hurt #biopharma from Pharmaceutical Executive.
Beyond the Buzz: Gauging the True Benefits of AI Today
https://lnkd.in/gRhZBQYD
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

